Delivery Order SPE2DB22D2007-SPE2DB24FJ5BV
Award Date
8/14/24
Potential Completion Date
8/15/24
Potential Value
$2.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,650.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 4, 2024. The $1,687.64 Firm Fixed Price contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product, to support DLA operations. This award is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,237.92, is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The contract is a delivery order placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,335.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a period of performance ending on May 12, 2025. The contract is a firm fixed-price arrangement, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $1,128.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product, with a performance period ending on May 21, 2025. This delivery order contract is a firm fixed-price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.56 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, with a value of $2,503.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a completion date of March 5, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp has a...
This is a $13,839.57 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a period of performance through January 31, 2025. This delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,615.78 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 26, 2024 with a completion date of August 27, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999 through December 2025...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The contract has a firm fixed price of $2,531.46 and a completion date of August 22, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these medical supplies to support the healthcare needs of military treatment facilities and other federal healthcare providers. This contract...